NASDAQ · HRMY
Healthcare · Biotechnology
$42.17
Up+$0.04 (+0.09%)
Updated Sep 16, 2026, 8:22 PM
SID Score
8.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
HRMY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning HRMY.
HRMY research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
1 matching article.
Benzinga · Sep 10, 2026
On September 9, it was revealed in an SEC filing that Kumar Budur, Chief Medical Officer at Harmony Biosciences Hldgs (NASDAQ:HRMY) executed a significant exercise of company stock options. What Happened: Budur, Chief
The latest Smart Investors Daily articles mentioning HRMY.
